Tofacitinib for Treatment of Moderate COVID-19
Clinical trial NCT04415151 · TERMINATED
Trial details
- NCT number
- NCT04415151
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2021-02-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.